Clinic Portfolios Safety 
The Dermatology Digest
MARCH 5, 2024
Additionally, more than 85% of clinical trial subjects were satisfied with how balanced, well-proportioned, and symmetric their face looked three months after treatment. The Allergan Medical Institute (AMI) team can train aesthetic providers on safe and effective treatments using the Allergan Aesthetics portfolio to address 90% of the face.
Southeastern Esthetics Institute
AUGUST 23, 2016
Specific courses for cosmetic lasers, for example, are crucial to add to the esthetics portfolio, in order to showcase added training beyond that of the esthetics fundamentals course. Esthetics practitioners within any advanced setting should obtain certifications underneath their license for each individual advanced procedure.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Dermatology Digest
JULY 1, 2024
The FDA’s approval of PYZCHIVA is based on a totality of evidence including analytical, non-clinical and clinical data demonstrating biosimilarity to Stelara, with no clinically meaningful differences in terms of safety, purity and potency.
The Dermatology Digest
AUGUST 30, 2024
The approval is based on previously available human safety data and data from a well-controlled animal study in which ACAM2000 vaccine was shown to be effective in protecting against mpox virus exposure. The clade I variant of mpox is characterized by more severe clinical outcomes and a higher case fatality rate.
The Dermatology Digest
MARCH 5, 2024
APG777 is the first clinical-stage product candidate from the company’s strategic collaboration with Paragon Therapeutics, Inc. Based on these data, the company plans to initiate a randomized, placebo-controlled, Phase 2 clinical trial in patients with moderate-to-severe AD in the first half of 2024 ahead of schedule.
Aesthetics Advisor
SEPTEMBER 15, 2023
Do note that some of them are available as over-the-counter medications but some are still under clinical trial or currently in development. Fewer clinical symptoms were also seen in the test group [57 cases (17.6%) vs 112 cases (34.6%), p < 0.0001]. And large clinical trials for nitric oxide nasal sprays are still taking place.
The Eco Well Blog
SEPTEMBER 18, 2022
He joined Colgate Palmolive, initially working in the Skin Basic Science research group and then founding and leading the Skin Clinical group. There, he led the Product Safety group for 25 years. His product safety portfolio included: Jergens and Curel lotions, Biore face care, Ban antiperspirant, and John Frieda hair care.
Expert insights. Personalized for you.
74 
Let's personalize your content